TINEA-VERSICOLOR - EPIDEMIOLOGIC, CLINICAL, AND THERAPEUTIC ASPECTS

被引:58
作者
BORELLI, D
JACOBS, PH
NALL, L
机构
[1] STANFORD UNIV,MED CTR,SCH MED,DEPT DERMATOL,STANFORD,CA 94305
[2] CENT UNIV VENEZUELA,CARACAS,VENEZUELA
关键词
D O I
10.1016/0190-9622(91)70198-B
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Age of the patient, climate, season, and local environmental factors influence the onset and course of tinea versicolor (pityriasis versicolor). A number of effective topical therapies are available. In addition, a single dose of 400 mg of oral ketoconazole eliminates the disease and can be used prophylactically in some cases to prevent recurrence.
引用
收藏
页码:300 / 305
页数:6
相关论文
共 36 条
[11]  
CAUWENBERGH G, 1987, KETOCONAZOLE TODAY R, P92
[12]  
CLISSOLD SP, 1987, KETOCONAZOLE TODAY R, P1
[13]  
CLISSOLD SP, 1987, KETOCONAZOLE TODAY R, P45
[14]   TINEA VERSICOLOR - SOME NEW ASPECTS ON ETIOLOGY, PATHOGENESIS, AND TREATMENT [J].
FAERGEMANN, J ;
FREDRIKSSON, T .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1982, 21 (01) :8-11
[15]   TINEA VERSICOLOR WITH REGARD TO SEBORRHEIC DERMATITIS - EPIDEMIOLOGICAL INVESTIGATION [J].
FAERGEMANN, J ;
FREDRIKSSON, T .
ARCHIVES OF DERMATOLOGY, 1979, 115 (08) :966-968
[16]   EXPERIMENTAL INFECTIONS IN RABBITS AND HUMANS WITH PITYROSPORUM-ORBICULARE AND PITYROSPORUM-OVALE [J].
FAERGEMANN, J ;
FREDRIKSSON, T .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1981, 77 (03) :314-318
[17]  
FAERGEMANN J, 1980, ACTA DERM-VENEREOL, V60, P531
[18]  
FAERGEMANN J, 1982, CUTIS, V30, P542
[19]  
FAERGEMANN J, 1985, ORAL THERAPY DERMATO
[20]  
Faergemann J. N., 1990, Antifungal drug therapy. A complete guide for the practitioner., P23